Categoria
Furadantin Retard
Nombres de marca,
Furadantin Retard
Analogos
Furadantin Retard
Marca los nombres de mezcla
No information avaliable
Furadantin Retard
Formula quimica
C8H6N4O5
Furadantin Retard
RX enlace
http://www.rxlist.com/cgi/generic/nitro25m.htm
Furadantin Retard
FDA hoja
Furadantin Retard
MSDS (hoja de seguridad de materiales)
Furadantin Retard
Sintesis de referencia
No hay información disponible
Furadantin Retard
Peso molecular
238.157 g/mol
Furadantin Retard
Punto de fusion
263 oC
Furadantin Retard
H2O Solubilidad
79.5 mg / L
Furadantin Retard
Estado
Solid
Furadantin Retard
LogP
-0.04
Furadantin Retard
Formas de dosificacion
Tableta
Furadantin Retard
Indicacion
Para el tratamiento de la infección del tracto urinario
Furadantin Retard
Farmacologia
Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.
Furadantin Retard
Absorcion
No hay información disponible
Furadantin Retard
Toxicidad
No hay información disponible
Furadantin Retard
Informacion de Pacientes
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
Furadantin Retard
Organismos afectados
Gram negativos y algunas bacterias gram positivas